UBS Group Has Lowered Expectations for ALX Oncology (NASDAQ:ALXO) Stock Price
ALX Oncology (NASDAQ:ALXO – Get Free Report) had its target price lowered by stock analysts at UBS Group from $1.20 to $1.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s target price points to a potential upside of 108.81% from the stock’s current […]
ALX Oncology (NASDAQ:ALXO – Get Free Report) had its target price lowered by stock analysts at UBS Group from $1.20 to $1.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s target price points to a potential upside of 108.81% from the stock’s current […]
